Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;50(7):2569-72.
doi: 10.1128/AAC.00291-06.

Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments

Cornelius J Clancy  1 , Hong Huang, Shaoji Cheng, Hartmut Derendorf, M Hong Nguyen
Affiliations

Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments

Cornelius J Clancy et al. Antimicrob Agents Chemother. 2006 Jul.

Abstract

We measured time-kills and postantifungal effects (PAFEs) of caspofungin against Candida albicans, C. parapsilosis, and C. glabrata isolates. One-hour exposure to caspofungin during PAFE experiments accounted for the majority of killing during time-kill experiments. Regrowth of all isolates was inhibited for at least 24 h following drug washout.

PubMed Disclaimer

Figures

FIG.1.
FIG.1.
Kill curves for time-kill (A) and postantifungal effect (B) experiments on C. albicans S. The kill curves at 0.25 times the MIC are not presented but did not show reductions in colony counts from the starting inocula.
FIG.2.
FIG.2.
Kill curves for time-kill (A) and postantifungal effect (B) experiments on C. parapsilosis 1. The kill curves at 0.25 times the MIC are not presented but did not show reductions in colony counts from the starting inocula.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Andes, D. 2003. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis. Antimicrob. Agents Chemother. 47:1179-1186. - PMC - PubMed
    1. Barchiesi, F., E. Spreghini, S. Tomassetti, D. Arzeni, D. Giannini, and G. Scalise. 2005. Comparison of the fungicidal activites of caspofungin and amphotericin B against Candida glabrata. Antimicrob. Agents Chemother. 49:4989-4992. - PMC - PubMed
    1. Bartizal, K., C. J. Gill, G. K. Abruzzo, A. M. Flattery, L. Kong, P. M. Scott, J. G. Smith, C. E. Leighton, A. Bouffard, J. F. Dropinski, and J. Balkovec. 1997. In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob. Agents Chemother. 41:2326-2332. - PMC - PubMed
    1. Bryan, L. E. 1989. Two forms of antimictobial resistance: bacterial persistence and positive function resistance. J. Antimicrob. Chemother. 23:817-823. - PubMed
    1. Denning, D. W. 2003. Echinocadin antifungal drugs. Lancet 362:1142-1151. - PubMed

Publication types

MeSH terms

LinkOut - more resources